Flinton Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $139K | Hold |
2,464
| – | – | ﹤0.01% | 726 |
|
|
2019
Q2 | $137K | Hold |
2,464
| – | – | ﹤0.01% | 738 |
|
|
2019
Q1 | $124K | Hold |
2,464
| – | – | ﹤0.01% | 746 |
|
|
2018
Q4 | $99K | Buy |
2,464
+476
| +24% | +$19.1K | ﹤0.01% | 750 |
|
|
2018
Q3 | $138K | Buy |
1,988
+168
| +9% | +$11.7K | ﹤0.01% | 755 |
|
|
2018
Q2 | $138K | Hold |
1,820
| – | – | ﹤0.01% | 717 |
|
|
2018
Q1 | $96K | Buy |
1,820
+308
| +20% | +$16.2K | ﹤0.01% | 763 |
|
|
2017
Q4 | $81K | Buy |
1,512
+280
| +23% | +$15K | ﹤0.01% | 787 |
|
|
2017
Q3 | $73K | Buy |
1,232
+364
| +42% | +$21.6K | ﹤0.01% | 778 |
|
|
2017
Q2 | $68K | Buy |
868
+476
| +121% | +$37.3K | ﹤0.01% | 768 |
|
|
2017
Q1 | $33K | Buy |
+392
| New | +$33K | ﹤0.01% | 792 |
|